CK19 IS A USEFUL MARKER IN DISTINGUISHING FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA FROM BENIGN THYROID LESIONS WITH FOLLICULAR GROWTH PATTERN

被引:3
作者
Noroozinia, F. [1 ]
Gheibi, A. [1 ]
Ilkhanizadeh, B. [1 ]
Abbasi, A. [1 ]
机构
[1] Urmia Univ Med Sci, Dept Pathol, Orumiyeh, Iran
关键词
thyroid nodule; Ck19; expression; growth pattern; MOLECULAR-WEIGHT CYTOKERATIN; DIFFERENTIAL-DIAGNOSIS; GALECTIN-3; HBME-1; IMMUNOHISTOCHEMISTRY; EXPRESSION; TUMORS; GLAND; CD56;
D O I
10.4183/aeb.2016.387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context. Thyroid cancer is the most common endocrine malignancy. Within various subtypes of thyroid neoplasms, those with follicular growth pattern usually make diagnostic problems. Objectives. To examine ck19 expression as a diagnostic marker in thyroid neoplasms with follicular growth pattern. Design. In this cross sectional study, 86 patients were enrolled. Subjects and Methods. Totally 22 follicular adenoma (FA), 18 well differentiated tumors with undetermined malignant potential (WT-UMP) and 46 follicular variants of papillary thyroid carcinoma (FV-PTC) were enrolled and examined for Ck19 expression by immunohistochemistry staining. Membranous/cytoplasmic staining patterns were considered as positive. Specimens without staining were considered as 0, <5% positively stained cells as 1+, 5%-25% as 2+, 25%-75% as 3+ and >75% as 4+. Result. CK19 was negative in most cases of FA while positive in most WDT-UMP and FV-PTCs, p<0.001. Additionally, most cases with 2+ and 3+ staining patterns were FV-PTC (75% and 81%, respectively, p<0.001) and none of FAs showed 3+ positivity (p<0.001). Additionally, most of strongly positive results in patients > 45 y/o were PTC (p<0.001). Conclusion. Ck19 is a useful marker in differentiating FA from FV-PTC. We found diffuse and strong (3+) staining pattern in FV-PTC but none of FAs were so. We concluded that diffuse and strong staining for ck19 in a thyroid lesion with follicular pattern of growth, especially in a patient older than 45 y/o should raise the possibility of malignancy.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 23 条
  • [1] Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules
    Beesley, MF
    McLaren, KM
    [J]. HISTOPATHOLOGY, 2002, 41 (03) : 236 - 243
  • [2] Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma
    Bose, Debdas
    Das, Ram Narayan
    Chatterjee, Uttara
    Banerjee, Uma
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (02) : 107 - 111
  • [3] Cytokeratin subtypes in thyroid tumours: Immunohistochemical study with emphasis on the follicular variant of papillary carcinoma
    Cameron, BR
    Berean, KW
    [J]. JOURNAL OF OTOLARYNGOLOGY, 2003, 32 (05) : 319 - 322
  • [4] Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1
    Casey, MB
    Lohse, CM
    Lloyd, RV
    [J]. ENDOCRINE PATHOLOGY, 2003, 14 (01) : 55 - 60
  • [5] Immunohistochemical diagnosis of papillary thyroid carcinoma
    Cheung, CC
    Ezzat, S
    Freeman, JL
    Rosen, IB
    Asa, SL
    [J]. MODERN PATHOLOGY, 2001, 14 (04) : 338 - 342
  • [6] Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas
    Choi, YL
    Kim, MK
    Suh, JW
    Han, J
    Kim, JH
    Yang, JH
    Nam, SJ
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (05) : 853 - 859
  • [7] Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy
    de Matos, PS
    Ferreira, AP
    Facuri, FD
    Assumpçao, LVM
    Metze, K
    Ward, LS
    [J]. HISTOPATHOLOGY, 2005, 47 (04) : 391 - 401
  • [8] Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature
    Dunderovic, Dusko
    Lipkovski, Jasmina Markovic
    Boricic, Ivan
    Soldatovic, Ivan
    Bozic, Vesna
    Cvejic, Dubravka
    Tatic, Svetislav
    [J]. DIAGNOSTIC PATHOLOGY, 2015, 10
  • [9] Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
    El Demellawy, Dina
    Nasr, Ahmed
    Alowami, Salem
    [J]. DIAGNOSTIC PATHOLOGY, 2008, 3 (1)
  • [10] Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins
    Fonseca, E
    Nesland, JM
    Hoie, J
    SobrinhoSimoes, M
    [J]. VIRCHOWS ARCHIV, 1997, 430 (03) : 239 - 245